CPHRF
Price
$10.90
Change
+$0.02 (+0.18%)
Updated
Aug 12 closing price
Capitalization
275.83M
85 days until earnings call
CURLF
Price
$2.72
Change
-$0.04 (-1.45%)
Updated
Aug 12 closing price
Capitalization
2.08B
89 days until earnings call
Interact to see
Advertisement

CPHRF vs CURLF

Header iconCPHRF vs CURLF Comparison
Open Charts CPHRF vs CURLFBanner chart's image
Cipher Pharmaceuticals
Price$10.90
Change+$0.02 (+0.18%)
Volume$14.68K
Capitalization275.83M
Curaleaf
Price$2.72
Change-$0.04 (-1.45%)
Volume$3.23M
Capitalization2.08B
CPHRF vs CURLF Comparison Chart in %
Loading...
CPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPHRF vs. CURLF commentary
Aug 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPHRF is a Buy and CURLF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 13, 2025
Stock price -- (CPHRF: $10.90 vs. CURLF: $2.72)
Brand notoriety: CPHRF and CURLF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CPHRF: 162% vs. CURLF: 314%
Market capitalization -- CPHRF: $275.83M vs. CURLF: $2.08B
CPHRF [@Pharmaceuticals: Generic] is valued at $275.83M. CURLF’s [@Pharmaceuticals: Generic] market capitalization is $2.08B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $66.38B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPHRF’s FA Score shows that 2 FA rating(s) are green whileCURLF’s FA Score has 0 green FA rating(s).

  • CPHRF’s FA Score: 2 green, 3 red.
  • CURLF’s FA Score: 0 green, 5 red.
According to our system of comparison, CPHRF is a better buy in the long-term than CURLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPHRF’s TA Score shows that 5 TA indicator(s) are bullish while CURLF’s TA Score has 4 bullish TA indicator(s).

  • CPHRF’s TA Score: 5 bullish, 5 bearish.
  • CURLF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CPHRF and CURLF are a good buy in the short-term.

Price Growth

CPHRF (@Pharmaceuticals: Generic) experienced а +14.62% price change this week, while CURLF (@Pharmaceuticals: Generic) price change was +41.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +5.29%. For the same industry, the average monthly price growth was +12.07%, and the average quarterly price growth was +82.46%.

Reported Earning Dates

CPHRF is expected to report earnings on Nov 06, 2025.

CURLF is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+5.29% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CURLF($2.08B) has a higher market cap than CPHRF($276M). CURLF YTD gains are higher at: 74.359 vs. CPHRF (9.373). CURLF has higher annual earnings (EBITDA): 223M vs. CPHRF (12.8M). CURLF has more cash in the bank: 122M vs. CPHRF (22M). CPHRF has less debt than CURLF: CPHRF (40.5M) vs CURLF (847M). CURLF has higher revenues than CPHRF: CURLF (1.31B) vs CPHRF (39.5M).
CPHRFCURLFCPHRF / CURLF
Capitalization276M2.08B13%
EBITDA12.8M223M6%
Gain YTD9.37374.35913%
P/E Ratio23.70N/A-
Revenue39.5M1.31B3%
Total Cash22M122M18%
Total Debt40.5M847M5%
FUNDAMENTALS RATINGS
CPHRF vs CURLF: Fundamental Ratings
CPHRF
CURLF
OUTLOOK RATING
1..100
1323
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
48
Fair valued
PROFIT vs RISK RATING
1..100
29100
SMR RATING
1..100
7096
PRICE GROWTH RATING
1..100
4334
P/E GROWTH RATING
1..100
8100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CURLF's Valuation (48) in the null industry is in the same range as CPHRF (64). This means that CURLF’s stock grew similarly to CPHRF’s over the last 12 months.

CPHRF's Profit vs Risk Rating (29) in the null industry is significantly better than the same rating for CURLF (100). This means that CPHRF’s stock grew significantly faster than CURLF’s over the last 12 months.

CPHRF's SMR Rating (70) in the null industry is in the same range as CURLF (96). This means that CPHRF’s stock grew similarly to CURLF’s over the last 12 months.

CURLF's Price Growth Rating (34) in the null industry is in the same range as CPHRF (43). This means that CURLF’s stock grew similarly to CPHRF’s over the last 12 months.

CPHRF's P/E Growth Rating (8) in the null industry is significantly better than the same rating for CURLF (100). This means that CPHRF’s stock grew significantly faster than CURLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPHRFCURLF
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 14 days ago
80%
Bearish Trend 30 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAZMX161.852.28
+1.43%
Oakmark R6
MMPCX21.010.25
+1.20%
NYLI WMC Value Class C
HWCIX29.83N/A
N/A
Hotchkis & Wiley Disciplined Value I
FIDEX13.68N/A
N/A
Fidelity SAI Sustainable U.S. Equity Fd
TADCX25.64N/A
N/A
Transamerica US Growth C

CPHRF and

Correlation & Price change

A.I.dvisor tells us that CPHRF and OGI have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHRF and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHRF
1D Price
Change %
CPHRF100%
+0.18%
OGI - CPHRF
23%
Poorly correlated
-3.05%
SDZNY - CPHRF
21%
Poorly correlated
+2.26%
CBWTF - CPHRF
8%
Poorly correlated
-0.82%
CANQF - CPHRF
6%
Poorly correlated
+39.60%
CURLF - CPHRF
5%
Poorly correlated
-1.45%
More

CURLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CURLF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURLF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURLF
1D Price
Change %
CURLF100%
-1.45%
GTBIF - CURLF
82%
Closely correlated
-3.76%
TCNNF - CURLF
80%
Closely correlated
-4.70%
VRNOF - CURLF
78%
Closely correlated
+7.13%
CRLBF - CURLF
76%
Closely correlated
+5.05%
TSNDF - CURLF
75%
Closely correlated
+1.33%
More